Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin
Open Access
- 1 July 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (28), 26039-26048
- https://doi.org/10.1074/jbc.m501972200
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- ALK receptor tyrosine kinase promotes cell growth and neurite outgrowthJournal of Cell Science, 2004
- An SCF-like ubiquitin ligase complex that controls presynaptic differentiationNature, 2004
- A ligand-inducible anaplastic lymphoma kinase chimera is endocytosis impairedOncogene, 2003
- Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicityBlood, 2003
- Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell linesOncogene, 2002
- Dominant Negative Effectors of Heparin Affin Regulatory Peptide (HARP) Angiogenic and Transforming ActivitiesPublished by Elsevier ,2002
- Identification of Both Positive and Negative Domains within the Epidermal Growth Factor Receptor COOH-terminal Region for Signal Transducer and Activator of Transcription (STAT) ActivationPublished by Elsevier ,2002
- Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cellsThe FASEB Journal, 2002
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Epitope mapping and functional studies with three monoclonal antibodies to the C‐KIT receptor tyrosine kinase, YB5.B8, 17F11, and SR‐1Journal of Cellular Physiology, 1994